Does IPILIMUMAB Cause Dermatitis? 167 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 167 reports of Dermatitis have been filed in association with IPILIMUMAB (YERVOY). This represents 0.5% of all adverse event reports for IPILIMUMAB.
167
Reports of Dermatitis with IPILIMUMAB
0.5%
of all IPILIMUMAB reports
17
Deaths
63
Hospitalizations
How Dangerous Is Dermatitis From IPILIMUMAB?
Of the 167 reports, 17 (10.2%) resulted in death, 63 (37.7%) required hospitalization, and 6 (3.6%) were considered life-threatening.
Is Dermatitis Listed in the Official Label?
Yes, Dermatitis is listed as a known adverse reaction in the official FDA drug label for IPILIMUMAB.
What Other Side Effects Does IPILIMUMAB Cause?
Death (3,710)
Malignant neoplasm progression (3,296)
Diarrhoea (2,557)
Off label use (2,097)
Colitis (1,988)
Pyrexia (1,796)
Rash (1,556)
Fatigue (1,447)
Intentional product use issue (1,329)
Nausea (1,169)
What Other Drugs Cause Dermatitis?
DUPILUMAB (3,823)
ADAPALENE (2,088)
AVOBENZONE\OCTISALATE\OCTOCRYLENE (1,615)
ADALIMUMAB (530)
METHOTREXATE (452)
ETANERCEPT (317)
SECUKINUMAB (294)
INFLIXIMAB (268)
NIVOLUMAB (251)
DENOSUMAB (246)
Which IPILIMUMAB Alternatives Have Lower Dermatitis Risk?
IPILIMUMAB vs IPRAGLIFLOZIN L-PROLINE
IPILIMUMAB vs IPRATROPIUM
IPILIMUMAB vs IPRATROPIUM\IPRATROPIUM ANHYDROUS
IPILIMUMAB vs IPTACOPAN
IPILIMUMAB vs IRBESARTAN